More
    Guided Solutions - Connecting Talent With Innovation/div>

    Stratus Medical raises $10M Series B to complete development of new technology

    Stratus Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced a $10 million Series B financing. The financing was...

    SonoVascular raises $6M Series A to support thrombectomy system

    SonoVascular announced that it completed the first close of its $6 million Series A financing round. Harbright Ventures served as leading investor. Following the round,...

    Bluedrop Medical picks up $1.2M for diabetic foot ulcer detection tech

    The Irish Independent reports that Bluedrop Medical secured approximately $1.2М in funding from Enterprise Ireland. Galway-based Bluedrop develops technology aimed at reducing the rate of...

    CraniUS closes $20M financing to support blood-brain barrier tech for drug delivery

    CraniUS Therapeutics announced that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a fully implantable,...

    Recare closes €37M funding round to scale AI platform and expand internationally

    Recare, a Berlin-based provider of technology solutions for hospitals and care providers, has closed a growth financing round of up to €37 million, including...

    Nami Surgical completes latest investment round and names new CEO

    Ultrasonic surgery specialist Nami Surgical has appointed Nikki Palfrey as CEO while completing its latest investment round. The company is targeting the global robotic-assisted...

    EIB provides €20M in financing to SamanTree Medical

    SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). The operation is...

    Medtronic to invest up to $90M in Anteris Technologies

    Anteris Technologies announced that medtech giant Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve developer. The private...

    LivsMed completes Korean IPO worth $94M

    LivsMed announced that it completed an initial public offering worth approximately $94 million on Korea’s KOSDAQ market. Seoul-based LivsMed said its offering drew “significant interest”...

    Latest articles